Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$74.43 - $92.22 $2,009 - $2,489
27 Added 0.61%
4,473 $368,000
Q1 2024

May 06, 2024

SELL
$83.81 - $99.0 $9,135 - $10,791
-109 Reduced 2.39%
4,446 $388,000
Q4 2023

Feb 13, 2024

SELL
$76.22 - $98.51 $24,314 - $31,424
-319 Reduced 6.54%
4,555 $439,000
Q3 2023

Nov 07, 2023

BUY
$85.07 - $94.48 $130,582 - $145,026
1,535 Added 45.97%
4,874 $431,000
Q2 2023

Aug 02, 2023

SELL
$86.68 - $100.3 $24,270 - $28,084
-280 Reduced 7.74%
3,339 $289,000
Q1 2023

May 10, 2023

SELL
$87.74 - $117.27 $210,137 - $280,861
-2,395 Reduced 39.82%
3,619 $351,000
Q4 2022

Feb 06, 2023

SELL
$80.93 - $108.63 $2,670 - $3,584
-33 Reduced 0.55%
6,014 $622,000
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $153,885 - $181,568
1,873 Added 44.87%
6,047 $513,000
Q2 2022

Aug 08, 2022

SELL
$71.48 - $86.85 $10,364 - $12,593
-145 Reduced 3.36%
4,174 $346,000
Q1 2022

May 12, 2022

SELL
$74.28 - $92.69 $523,896 - $653,742
-7,053 Reduced 62.02%
4,319 $333,000
Q4 2021

Feb 02, 2022

BUY
$71.72 - $91.47 $9,251 - $11,799
129 Added 1.15%
11,372 $1.01 Million
Q3 2021

Nov 12, 2021

SELL
$74.77 - $85.47 $455,124 - $520,255
-6,087 Reduced 35.12%
11,243 $869,000
Q2 2021

Aug 03, 2021

BUY
$75.51 - $84.79 $44,928 - $50,450
595 Added 3.56%
17,330 $1.45 Million
Q1 2021

May 17, 2021

SELL
$74.73 - $90.69 $790,195 - $958,956
-10,574 Reduced 38.72%
16,735 $1.26 Million
Q4 2020

Feb 11, 2021

BUY
$72.61 - $90.2 $99,112 - $123,123
1,365 Added 5.26%
27,309 $2.4 Million
Q3 2020

Nov 13, 2020

BUY
$71.87 - $131.03 $104,427 - $190,386
1,453 Added 5.93%
25,944 $1.97 Million
Q2 2020

Aug 11, 2020

BUY
$79.55 - $124.22 $72,310 - $112,915
909 Added 3.85%
24,491 $3.02 Million
Q1 2020

May 08, 2020

BUY
$71.37 - $96.85 $276,059 - $374,615
3,868 Added 19.62%
23,582 $1.99 Million
Q4 2019

Feb 07, 2020

SELL
$64.27 - $86.37 $75,388 - $101,312
-1,173 Reduced 5.62%
19,714 $1.67 Million
Q3 2019

Oct 31, 2019

BUY
$67.4 - $85.11 $124,690 - $157,453
1,850 Added 9.72%
20,887 $1.41 Million
Q2 2019

Aug 09, 2019

SELL
$80.35 - $93.9 $8,758 - $10,235
-109 Reduced 0.57%
19,037 $1.63 Million
Q1 2019

Apr 24, 2019

SELL
$84.2 - $98.62 $940,598 - $1.1 Million
-11,171 Reduced 36.85%
19,146 $1.7 Million
Q4 2018

Jan 30, 2019

BUY
$80.14 - $106.07 $80 - $106
1 Added 0.0%
30,317 $2.58 Million
Q3 2018

Oct 26, 2018

BUY
$93.92 - $105.72 $66,025 - $74,321
703 Added 2.37%
30,316 $2.94 Million
Q2 2018

Aug 10, 2018

BUY
$76.01 - $99.03 $284,809 - $371,065
3,747 Added 14.49%
29,613 $2.79 Million
Q1 2018

May 09, 2018

BUY
$77.67 - $92.63 $73,631 - $87,813
948 Added 3.8%
25,866 $2.1 Million
Q3 2017

Nov 14, 2017

BUY
$80.6 - $94.95 $2.01 Million - $2.37 Million
24,918
24,918 $2.32 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.